|Bid||218.02 x 800|
|Ask||218.99 x 800|
|Day's range||212.22 - 218.60|
|52-week range||200.32 - 280.72|
|Beta (5Y monthly)||1.06|
|PE ratio (TTM)||15.56|
|Earnings date||26 Apr 2023 - 01 May 2023|
|Forward dividend & yield||2.88 (1.34%)|
|Ex-dividend date||22 Feb 2023|
|1y target est||285.42|
Investors are optimistic about LabCorp (LH) backed by strength in its Drug Development business.
In its efforts to expand further, LabCorp (LH) is focusing more on high-growth opportunity areas such as neurodegenerative, autoimmune and liver disease as well as cell and gene therapy.
Today's Research Daily features new research reports on 16 major stocks, including TotalEnergies SE (TTE), America Movil, S.A.B. de C.V. (AMX) and Palo Alto Networks, Inc. (PANW).